Cargando…
Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro
Extracellular vesicles (EV) secreted in the tumour microenvironment (TME) are emerging as major antagonists of anticancer therapies by orchestrating the therapeutic outcome through altering the behaviour of recipient cells. Recent evidence suggested that chemotherapeutic drugs could be responsible f...
Autores principales: | Patras, Laura, Fens, Marcel H. A. M., Vader, Pieter, Barendrecht, Arjan, Sesarman, Alina, Banciu, Manuela, Schiffelers, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503554/ https://www.ncbi.nlm.nih.gov/pubmed/32824972 http://dx.doi.org/10.3390/ijms21175951 |
Ejemplares similares
-
Divergent mutational processes distinguish hypoxic and normoxic tumours
por: Bhandari, Vinayak, et al.
Publicado: (2020) -
Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
por: Bhandari, Vinayak, et al.
Publicado: (2022) -
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
por: Negrea, Giorgiana, et al.
Publicado: (2022) -
Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2017) -
Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo
por: Patras, Laura, et al.
Publicado: (2021)